# Nuvectis Pharma, Inc. (NVCT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NVCT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -6.05M | $ -6.51M | $ 0 | $ 14.22M |
| 2025 | $ 0 | $ -27.07M | $ -16.39M | $ 0 | $ 18.41M |
| 2024 | $ 0 | $ -19.97M | $ -12.87M | $ 0 | $ 9.71M |
| 2023 | $ 0 | $ -24.07M | $ -17.25M | $ 0 | $ 12.20M |
| 2022 | $ 0 | $ -21.32M | $ -15.15M | $ 0 | $ 14.22M |
| 2021 | $ 0 | $ -15.32M | $ -11.30M | $ 0 | $ -11.01M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.79 |
| Current Ratio | 2.27 |

## Other views

- [Metrics](https://sponda.capital/en/NVCT.md)
- [Charts](https://sponda.capital/en/NVCT/charts.md)
- [Compare](https://sponda.capital/en/NVCT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.